JP2022516537A5 - - Google Patents
Info
- Publication number
- JP2022516537A5 JP2022516537A5 JP2021538362A JP2021538362A JP2022516537A5 JP 2022516537 A5 JP2022516537 A5 JP 2022516537A5 JP 2021538362 A JP2021538362 A JP 2021538362A JP 2021538362 A JP2021538362 A JP 2021538362A JP 2022516537 A5 JP2022516537 A5 JP 2022516537A5
- Authority
- JP
- Japan
- Prior art keywords
- syndrome
- agonist according
- ampk agonist
- mitochondrial
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862786970P | 2018-12-31 | 2018-12-31 | |
| US62/786,970 | 2018-12-31 | ||
| PCT/US2019/069145 WO2020142547A1 (en) | 2018-12-31 | 2019-12-31 | Methods and formulations to treat mitochondrial dysfunction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022516537A JP2022516537A (ja) | 2022-02-28 |
| JP2022516537A5 true JP2022516537A5 (enExample) | 2023-01-04 |
| JP7511564B2 JP7511564B2 (ja) | 2024-07-05 |
Family
ID=71406802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538362A Active JP7511564B2 (ja) | 2018-12-31 | 2019-12-31 | ミトコンドリア機能不全を治療する方法及び配合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12377077B2 (enExample) |
| EP (1) | EP3906027A4 (enExample) |
| JP (1) | JP7511564B2 (enExample) |
| KR (1) | KR20210110636A (enExample) |
| CN (1) | CN113347972B (enExample) |
| BR (1) | BR112021012799A8 (enExample) |
| CA (1) | CA3124838A1 (enExample) |
| WO (1) | WO2020142547A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119013256A (zh) * | 2022-01-25 | 2024-11-22 | Evvia治疗公司 | Ampk激动剂及其使用方法 |
| WO2024036044A1 (en) * | 2022-08-08 | 2024-02-15 | The Johns Hopkins University | Compositions and methods for treating and preventing metabolic disorders |
| KR20240109203A (ko) * | 2022-12-29 | 2024-07-10 | 주식회사 엣진 | 레베르 유전성 시신경병증의 미토콘드리아 염기 변이 교정 시스템 |
| WO2024209363A1 (en) * | 2023-04-06 | 2024-10-10 | Pfizer Inc. | Substituted indazole propionic acid derivative compounds and uses thereof as ampk activators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012114204A2 (en) * | 2011-02-15 | 2012-08-30 | Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto | Methods of treating mitochondrial dysfunction |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| WO2014180908A1 (en) | 2013-05-08 | 2014-11-13 | Deutsches Krebsforschungszentrum | Acip/peptide-based inhibition of cancer cachexia |
| JP2016533385A (ja) | 2013-08-22 | 2016-10-27 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | アルキニルアルコール及び使用方法 |
| WO2018118808A1 (en) | 2016-12-19 | 2018-06-28 | The Broad Institute, Inc. | Methods of treating autism spectrum disorders |
-
2019
- 2019-12-31 JP JP2021538362A patent/JP7511564B2/ja active Active
- 2019-12-31 WO PCT/US2019/069145 patent/WO2020142547A1/en not_active Ceased
- 2019-12-31 CN CN201980087513.1A patent/CN113347972B/zh active Active
- 2019-12-31 BR BR112021012799A patent/BR112021012799A8/pt not_active Application Discontinuation
- 2019-12-31 EP EP19907633.2A patent/EP3906027A4/en active Pending
- 2019-12-31 US US17/419,477 patent/US12377077B2/en active Active
- 2019-12-31 KR KR1020217023553A patent/KR20210110636A/ko not_active Withdrawn
- 2019-12-31 CA CA3124838A patent/CA3124838A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504963A5 (enExample) | ||
| DE69517957T2 (de) | 5-substituierte derivate von mycophenolsäure | |
| JP2016515527A5 (enExample) | ||
| EP2029552B1 (de) | Sulfimide als proteinkinaseinhibitoren | |
| CA2341700A1 (en) | Compositions and methods for treatment of mitochondrial diseases | |
| JP2016515526A5 (enExample) | ||
| EP2059511A1 (de) | Sulfoximide als proteinkinaseinhibitoren | |
| EP1161423A1 (de) | Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel | |
| WO2008074515A1 (de) | Neuartige hetaryl-phenylendiamin-pyrimidine als proteinkinaseinhibitoren zur behandlung von krebs | |
| JP2005527627A5 (enExample) | ||
| JP7511564B2 (ja) | ミトコンドリア機能不全を治療する方法及び配合物 | |
| JP2021527045A5 (enExample) | ||
| JP2021527061A5 (enExample) | ||
| WO2003006443A2 (de) | 2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie | |
| DE3927931A1 (de) | Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate | |
| DE4128681A1 (de) | Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln | |
| JP2024530008A (ja) | インドール誘導体、その製造方法および薬学的用途 | |
| EP0239816B1 (de) | N,N'-substituierte Bis-(2,4-diamino-s-triazin-6-yl)-Tetrasulfide und ihre Disproportionierungsprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung in vulkanisierbaren Kautschukmischungen | |
| CN104844628B (zh) | 2H,6H‑嘧啶并[2,1‑b][1,3]噻嗪类衍生物及其应用 | |
| WO2005047278A2 (de) | Substituierte dihydrochinazoline ii | |
| JP2021534084A5 (enExample) | ||
| EP0064657B1 (de) | Ringförmige Sulfenamide, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Herstellung | |
| CN105132115B (zh) | 一种耐高温水基石墨芯棒润滑剂 | |
| DE102013018353A1 (de) | Reifenelement und Verfahren für dessen Herstellung | |
| DE3316093A1 (de) | Allylaminderivate, verfahren zu ihrer herstellung und ihre verwendung |